Rbc Life Sciences Stock Net Income
| RBCL Stock | USD 0.0006 0.00 0.00% |
As of the 17th of February 2026, RBC Life owns the market risk adjusted performance of (1.37), and Coefficient Of Variation of 601.79. In respect to fundamental indicators, the technical analysis model allows you to check possible technical drivers of RBC Life Sciences, as well as the relationship between them. Please check RBC Life Sciences mean deviation, total risk alpha, as well as the relationship between the Total Risk Alpha and kurtosis to decide if RBC Life Sciences is priced fairly, providing market reflects its prevailing price of 6.0E-4 per share. As RBC Life Sciences appears to be a penny stock we also advise to check out its information ratio numbers.
RBC Life's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing RBC Life's valuation are provided below:RBC Life Sciences does not right now have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. RBC |
RBC Life 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to RBC Life's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of RBC Life.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in RBC Life on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding RBC Life Sciences or generate 0.0% return on investment in RBC Life over 90 days. RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in Nor... More
RBC Life Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure RBC Life's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess RBC Life Sciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1611 | |||
| Maximum Drawdown | 100.0 |
RBC Life Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for RBC Life's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as RBC Life's standard deviation. In reality, there are many statistical measures that can use RBC Life historical prices to predict the future RBC Life's volatility.| Risk Adjusted Performance | 0.1435 | |||
| Jensen Alpha | 2.36 | |||
| Total Risk Alpha | 1.25 | |||
| Treynor Ratio | (1.38) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of RBC Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
RBC Life February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1435 | |||
| Market Risk Adjusted Performance | (1.37) | |||
| Mean Deviation | 4.41 | |||
| Coefficient Of Variation | 601.79 | |||
| Standard Deviation | 13.68 | |||
| Variance | 187.06 | |||
| Information Ratio | 0.1611 | |||
| Jensen Alpha | 2.36 | |||
| Total Risk Alpha | 1.25 | |||
| Treynor Ratio | (1.38) | |||
| Maximum Drawdown | 100.0 | |||
| Skewness | 6.46 | |||
| Kurtosis | 43.34 |
RBC Life Sciences Backtested Returns
RBC Life is out of control given 3 months investment horizon. RBC Life Sciences retains Efficiency (Sharpe Ratio) of 0.17, which implies the company had a 0.17 % return per unit of risk over the last 3 months. We were able to break down sixteen different technical indicators, which can help you to evaluate if expected returns of 2.42% are justified by taking the suggested risk. Use RBC Life Sciences coefficient of variation of 601.79, and Market Risk Adjusted Performance of (1.37) to evaluate company specific risk that cannot be diversified away. RBC Life holds a performance score of 13 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of -1.64, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning RBC Life are expected to decrease by larger amounts. On the other hand, during market turmoil, RBC Life is expected to outperform it. Use RBC Life Sciences mean deviation, information ratio, as well as the relationship between the Information Ratio and kurtosis , to analyze future returns on RBC Life Sciences.
Auto-correlation | 0.53 |
Modest predictability
RBC Life Sciences has modest predictability. Overlapping area represents the amount of predictability between RBC Life time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of RBC Life Sciences price movement. The serial correlation of 0.53 indicates that about 53.0% of current RBC Life price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.53 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, RBC Life Sciences reported net income of (756,284). This is 100.07% lower than that of the Personal Products sector and 100.08% lower than that of the Consumer Staples industry. The net income for all United States stocks is 100.13% higher than that of the company.
RBC Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RBC Life's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of RBC Life could also be used in its relative valuation, which is a method of valuing RBC Life by comparing valuation metrics of similar companies.RBC Life is currently under evaluation in net income category among its peers.
RBC Fundamentals
| Return On Equity | -0.0677 | |||
| Return On Asset | -0.1 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | (0.1) % | |||
| Current Valuation | (601.15 K) | |||
| Shares Outstanding | 2.21 M | |||
| Shares Owned By Insiders | 8.31 % | |||
| Price To Earning | (0.75) X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 25.77 M | |||
| Gross Profit | 15.64 M | |||
| EBITDA | (1.79 M) | |||
| Net Income | (756.28 K) | |||
| Cash And Equivalents | 2.09 M | |||
| Cash Per Share | 0.94 X | |||
| Debt To Equity | 0.14 % | |||
| Current Ratio | 2.16 X | |||
| Book Value Per Share | 3.63 X | |||
| Cash Flow From Operations | 155.53 K | |||
| Earnings Per Share | (0.25) X | |||
| Number Of Employees | 89 | |||
| Beta | -10.1 | |||
| Market Capitalization | 126.14 K | |||
| Total Asset | 10.96 M | |||
| Retained Earnings | (6.75 M) | |||
| Working Capital | 4.06 M | |||
| Current Asset | 7.88 M | |||
| Current Liabilities | 3.82 M | |||
| Z Score | 2.0 | |||
| Net Asset | 10.96 M |
About RBC Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RBC Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RBC Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RBC Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in RBC Pink Sheet
RBC Life financial ratios help investors to determine whether RBC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Life security.